TUMOUR BRCA TEST ALL YOUR NEWLY DIAGNOSED ADVANCED OVARIAN CANCER PATIENTS TO IDENTITY THOSE WHO MAY BENEFIT FROM LYNPARZA 1L1,2,13
Tumour BRCA testing service
AstraZeneca are offering a tumor BRCA testing service at specified collaboration laboratories for patients who meet the eligibility criteria.
Who is eligible for this service?
Patients who are eligible for this service are those that have ovarian cancer and either a known negative germline BRCA mutation status or an unknown germline BRCA mutation status. Patients must have received at least two prior lines of treatment (i.e.